Try our Advanced Search for more refined results

Regeneron Pharmaceuticals, Inc., Petitioner v. Merus N.V.

  1. August 10, 2018

    Merus Asks High Court To Bat Down Mouse Patent Appeal

    Merus NV has urged the U.S. Supreme Court to keep in place a lower court's decision that rendered Regeneron Pharmaceuticals Inc.'s genetically modified mouse patent unenforceable due to inequitable conduct during infringement litigation, saying its rival is attempting to "rewrite history."

  2. July 11, 2018

    IP Pros Urge High Court To Hear Inequitable Conduct Case

    Several intellectual property attorneys and associations have urged the U.S. Supreme Court to review a case where a patent was rendered unenforceable over inequitable conduct during infringement litigation, warning the ruling against Regeneron Pharmaceuticals Inc. would undermine the patent system.

  3. June 04, 2018

    Regeneron Urges Justices To Ax Inequitable Conduct Ruling

    Regeneron has urged the U.S. Supreme Court to reverse a ruling that its patent for a genetically modified mouse is unenforceable due to inequitable conduct, saying the finding was wrongly based on misconduct during litigation and threatens to "wreak havoc" on the patent system.